Difference between revisions of "Peter Doyle"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
| − | Until summer 2003 Dr Peter Doyle was Chairman of the | + | Until summer 2003 Dr Peter Doyle was Chairman of the UK's main public funding body, the [[Biotechnology and Biological Sciences Research Council]] (BBSRC), which is overseen by [[Lord David Sainsbury]]'s Government department |
| Line 11: | Line 11: | ||
| − | Zeneca under Doyle committed itself to investing | + | Zeneca under Doyle committed itself to investing million in the [[John Innes Centre]] in Norwich, which is funded by the BBSRC and [[Lord David Sainsbury]] through his [[Gatsby Charitable Foundation]]. |
On leaving Zeneca, Peter Doyle joined the board of genomics company Oxagen Ltd (1999-2002). Doyle was also a non-executive director of Oxford Molecular PLC (1997-2000). He is a non-executive director of Avidex. He is also a trustee of the Nuffield Foundation and the AstraZeneca Science Teaching Trust, which is chaired by Dame [[Bridget Ogilvie]], and previously was a member of the Medical Research Council, and the Prime Minster's Advisory Committee on Science and Technology. | On leaving Zeneca, Peter Doyle joined the board of genomics company Oxagen Ltd (1999-2002). Doyle was also a non-executive director of Oxford Molecular PLC (1997-2000). He is a non-executive director of Avidex. He is also a trustee of the Nuffield Foundation and the AstraZeneca Science Teaching Trust, which is chaired by Dame [[Bridget Ogilvie]], and previously was a member of the Medical Research Council, and the Prime Minster's Advisory Committee on Science and Technology. | ||